COVID:

Thomas H Marwick1, Noah Wexler2, Joel Smith3

  • 1Imaging Research Lab, Baker Heart and Diabetes Institute, Hobart, Tasmania, Australia; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia; Department of Cardiology, Western Health, Melbourne, Victoria, Australia; Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia; Cardiovascular Health Flagship, Menzies Institute for Medical Research, Hobart, Tasmania, Australia.

概括

长期COVID与亚临床心脏功能障碍,特别是左心室尺寸变化和全球纵向应变 (GLS) 损伤有关. 这种心脏功能障碍独立于传统的风险因素,并导致患者的功能限制.